Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $1.36 billion. The enterprise value is $1.03 billion.
Important Dates
The last earnings date was Thursday, November 14, 2024, before market open.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 157.22 million shares outstanding. The number of shares has increased by 76.20% in one year.
| Current Share Class | 157.22M |
| Shares Outstanding | 157.22M |
| Shares Change (YoY) | +76.20% |
| Shares Change (QoQ) | +0.70% |
| Owned by Insiders (%) | 2.18% |
| Owned by Institutions (%) | 68.62% |
| Float | 120.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.63 |
| Forward PS | 19.21 |
| PB Ratio | 3.91 |
| P/TBV Ratio | 3.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.01, with a Debt / Equity ratio of 0.21.
| Current Ratio | 13.01 |
| Quick Ratio | 12.58 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.66 |
Financial Efficiency
Return on equity (ROE) is -96.89% and return on invested capital (ROIC) is -34.09%.
| Return on Equity (ROE) | -96.89% |
| Return on Assets (ROA) | -27.05% |
| Return on Capital (ROIC) | -34.09% |
| Revenue Per Employee | $230,120 |
| Profits Per Employee | -$652,951 |
| Employee Count | 267 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 46.60 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +285.09% in the last 52 weeks. The beta is 1.26, so OCUL's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | +285.09% |
| 50-Day Moving Average | 9.90 |
| 200-Day Moving Average | 8.08 |
| Relative Strength Index (RSI) | 33.65 |
| Average Volume (20 Days) | 929,384 |
Short Selling Information
The latest short interest is 12.67 million, so 8.06% of the outstanding shares have been sold short.
| Short Interest | 12.67M |
| Short Previous Month | 13.26M |
| Short % of Shares Out | 8.06% |
| Short % of Float | 10.54% |
| Short Ratio (days to cover) | 9.68 |
Income Statement
In the last 12 months, OCUL had revenue of $61.44 million and -$174.34 million in losses. Loss per share was -$1.27.
| Revenue | 61.44M |
| Gross Profit | -47.18M |
| Operating Income | -141.26M |
| Pretax Income | -138.36M |
| Net Income | -174.34M |
| EBITDA | -137.46M |
| EBIT | -141.26M |
| Loss Per Share | -$1.27 |
Full Income StatementBalance Sheet
The company has $427.22 million in cash and $75.12 million in debt, giving a net cash position of $352.10 million or $2.24 per share.
| Cash & Cash Equivalents | 427.22M |
| Total Debt | 75.12M |
| Net Cash | 352.10M |
| Net Cash Per Share | $2.24 |
| Equity (Book Value) | 352.02M |
| Book Value Per Share | 2.25 |
| Working Capital | 436.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$117.70 million and capital expenditures -$1.55 million, giving a free cash flow of -$119.25 million.
| Operating Cash Flow | -117.70M |
| Capital Expenditures | -1.55M |
| Free Cash Flow | -119.25M |
| FCF Per Share | -$0.76 |
Full Cash Flow StatementMargins
Gross margin is -76.79%, with operating and profit margins of -229.90% and -283.74%.
| Gross Margin | -76.79% |
| Operating Margin | -229.90% |
| Pretax Margin | -283.74% |
| Profit Margin | -283.74% |
| EBITDA Margin | -223.73% |
| EBIT Margin | -229.90% |
| FCF Margin | -148.27% |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -76.20% |
| Shareholder Yield | -76.20% |
| Earnings Yield | -12.75% |
| FCF Yield | -8.72% |
Analyst Forecast
The average price target for OCUL is $16.50, which is 90.97% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.50 |
| Price Target Difference | 90.97% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 41.32% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 1.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.48 |
| Piotroski F-Score | 3 |